2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)

TY - JOUR

T1 - 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

T2 - The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)

AU - Ibanez, Borja

AU - James, Stefan

AU - Agewall, Stefan

AU - Antunes, Manuel J.

AU - Bucciarelli-Ducci, Chiara

AU - Bueno, Hector

AU - Caforio, Alida L.P.

AU - Crea, Filippo

AU - Goudevenos, John A.

AU - Halvorsen, Sigrun

AU - Hindricks, Gerhard

AU - Kastrati, Adnan

AU - Lenzen, Mattie J.

AU - Prescott, Eva

AU - Roffi, Marco

AU - Valgimigli, Marco

AU - Varenhorst, Christoph

AU - Vranckx, Pascal

AU - Widimský, Petr

AU - Baumbach, Andreas

AU - Bugiardini, Raffaele

AU - Coman, Ioan Mircea

AU - Delgado, Victoria

AU - Fitzsimons, Donna

AU - Gaemperli, Oliver

AU - Gershlick, Anthony H.

AU - Gielen, Stephan

AU - Harjola, Veli Pekka

AU - Katus, Hugo A.

AU - Knuuti, Juhani

AU - Kolh, Philippe

AU - Leclercq, Christophe

AU - Lip, Gregory Y.H.

AU - Morais, Joao

AU - Neskovic, Aleksandar N.

AU - Neumann, Franz Josef

AU - Niessner, Alexander

AU - Piepoli, Massimo Francesco

AU - Richter, Dimitrios J.

AU - Shlyakhto, Evgeny

AU - Simpson, Iain A.

AU - Steg, Ph Gabriel

AU - Terkelsen, Christian Juhl

AU - Thygesen, Kristian

AU - Windecker, Stephan

AU - Zamorano, Jose Luis

AU - Zeymer, Uwe

AU - Chettibi, Mohamed

AU - Hayrapetyan, Hamlet G.

AU - Metzler, Bernhard

AU - ESC National Cardiac Societies

PY - 2018

Y1 - 2018

N2 - The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

AB - The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

KW - Acute coronary syndromes

KW - Acute myocardial infarction

KW - Antithrombotic therapy

KW - Antithrombotics

KW - Emergency medical system

KW - Evidence

KW - Fibrinolysis

KW - Guidelines

KW - Ischaemic heart disease

KW - MINOCA

KW - Primary percutaneous coronary intervention

KW - Quality indicators

KW - Reperfusion therapy

KW - Risk assessment

KW - Secondary prevention

KW - ST-segment elevation.

U2 - 10.1093/eurheartj/ehx393

DO - 10.1093/eurheartj/ehx393

M3 - Review

C2 - 28886621

AN - SCOPUS:85040602547

SN - 0195-668X

VL - 39

SP - 119

EP - 177

JO - European Heart Journal

JF - European Heart Journal

IS - 2

ER -